Safety and dose modification for patients receiving niraparib
Berek, J.S., Matulonis, U.A., Peen, U., Ghatage, P., Mahner, S., Redondo, A., Lesoin, A., Colombo, N., Vergote, I., Rosengarten, O., Ledermann, J., Pineda, M., Ellard, S., Sehouli, J., Gonzalez-Martin, A., Berton-Rigaud, D., Madry, R., Reinthaller, A., Hazard, S., Guo, W., Mirza, M.R.
Published in Annals of oncology (01.08.2018)
Published in Annals of oncology (01.08.2018)
Get full text
Journal Article
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease
Wilson, M.K., Pujade-Lauraine, E., Aoki, D., Mirza, M.R., Lorusso, D., Oza, A.M., du Bois, A., Vergote, I., Reuss, A., Bacon, M., Friedlander, M., Gallardo-Rincon, D., Joly, F., Chang, S.-J., Ferrero, A.M., Edmondson, R.J., Wimberger, P., Maenpaa, J., Gaffney, D., Zang, R., Okamoto, A., Stuart, G., Ochiai, K.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
Conference Proceeding
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
Van Gorp, T, Cadron, I, Despierre, E, Daemen, A, Leunen, K, Amant, F, Timmerman, D, De Moor, B, Vergote, I
Published in British journal of cancer (01.03.2011)
Published in British journal of cancer (01.03.2011)
Get full text
Journal Article
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
Matulonis, U.A., Shapira-Frommer, R., Santin, A.D., Lisyanskaya, A.S., Pignata, S., Vergote, I., Raspagliesi, F., Sonke, G.S., Birrer, M., Provencher, D.M., Sehouli, J., Colombo, N., González-Martín, A., Oaknin, A., Ottevanger, P.B., Rudaitis, V., Katchar, K., Wu, H., Keefe, S., Ruman, J., Ledermann, J.A.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Colombo, N, Sessa, C, du Bois, A, Ledermann, J, McCluggage, W G, McNeish, I, Morice, P, Pignata, S, Ray-Coquard, I, Vergote, I, Baert, T, Belaroussi, I, Dashora, A, Olbrecht, S, Planchamp, F, Querleu, D
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Conference Proceeding
Web Resource
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Moore, K.N., Oza, A.M., Colombo, N., Oaknin, A., Scambia, G., Lorusso, D., Konecny, G.E., Banerjee, S., Murphy, C.G., Tanyi, J.L., Hirte, H., Konner, J.A., Lim, P.C., Prasad-Hayes, M., Monk, B.J., Pautier, P., Wang, J., Berkenblit, A., Vergote, I., Birrer, M.J.
Published in Annals of oncology (01.06.2021)
Published in Annals of oncology (01.06.2021)
Get full text
Journal Article
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Colombo, N, Sessa, C, Bois, A du, Ledermann, J, McCluggage, W G, McNeish, I, Morice, P, Pignata, S, Ray-Coquard, I, Vergote, I, Baert, T, Belaroussi, I, Dashora, A, Olbrecht, S, Planchamp, F, Querleu, D
Published in International journal of gynecological cancer (01.05.2019)
Published in International journal of gynecological cancer (01.05.2019)
Get full text
Journal Article
Web Resource
ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors
Timmerman, D., Planchamp, F., Bourne, T., Landolfo, C., du Bois, A., Chiva, L., Cibula, D., Concin, N., Fischerova, D., Froyman, W., Gallardo, G., Lemley, B., Loft, A., Mereu, L., Morice, P., Querleu, D., Testa, A. C., Vergote, I., Vandecaveye, V., Scambia, G., Fotopoulou, C.
Published in Ultrasound in obstetrics & gynecology (01.07.2021)
Published in Ultrasound in obstetrics & gynecology (01.07.2021)
Get full text
Journal Article
Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer
Van Raemdonck, Elisa, Floris, G., Berteloot, P., Laenen, A., Vergote, I., Wildiers, H., Punie, K., Neven, P.
Published in Breast cancer research and treatment (01.01.2021)
Published in Breast cancer research and treatment (01.01.2021)
Get full text
Journal Article
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
Ray-Coquard, I., Leary, A., Pignata, S., Cropet, C., González-Martín, A., Marth, C., Nagao, S., Vergote, I., Colombo, N., Mäenpää, J., Selle, F., Sehouli, J., Lorusso, D., Guerra Alia, E.M., Bogner, G., Yoshida, H., Lefeuvre-Plesse, C., Buderath, P., Mosconi, A.M., Lortholary, A., Burges, A., Medioni, J., El-Balat, A., Rodrigues, M., Park-Simon, T.-W., Dubot, C., Denschlag, D., You, B., Pujade-Lauraine, E., Harter, P.
Published in Annals of oncology (01.08.2023)
Published in Annals of oncology (01.08.2023)
Get full text
Journal Article
Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies
Kaijser, J., Bourne, T., Valentin, L., Sayasneh, A., Van Holsbeke, C., Vergote, I., Testa, A. C., Franchi, D., Van Calster, B., Timmerman, D.
Published in Ultrasound in obstetrics & gynecology (01.01.2013)
Published in Ultrasound in obstetrics & gynecology (01.01.2013)
Get full text
Journal Article
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
WAGNER, U, MARTH, C, GEBSKI, V, LAURAINE, E. P, LARGILLIER, R, KAERN, J, BROWN, C, HEYWOOD, M, BONAVENTURA, T, VERGOTE, I, PICCIRILLO, M. C, FOSSATI, R
Published in British journal of cancer (07.08.2012)
Published in British journal of cancer (07.08.2012)
Get full text
Journal Article
Simple ultrasound‐based rules for the diagnosis of ovarian cancer
Timmerman, D., Testa, A. C., Bourne, T., Ameye, L., Jurkovic, D., Van Holsbeke, C., Paladini, D., Van Calster, B., Vergote, I., Van Huffel, S., Valentin, L.
Published in Ultrasound in obstetrics & gynecology (01.06.2008)
Published in Ultrasound in obstetrics & gynecology (01.06.2008)
Get full text
Journal Article
Primary invasive mucinous ovarian carcinoma of the intestinal type: Importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases
Muyldermans, K, Moerman, Ph, Amant, F, Leunen, K, Neven, P, Vergote, I
Published in European journal of cancer (1990) (01.05.2013)
Published in European journal of cancer (1990) (01.05.2013)
Get full text
Journal Article
A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel
Vergote, I., Bergfeldt, K., Franquet, A., Lisyanskaya, A.S., Bjermo, H., Heldring, N., Buyse, M., Brize, A.
Published in Gynecologic oncology (01.02.2020)
Published in Gynecologic oncology (01.02.2020)
Get full text
Journal Article
Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I
te Grootenhuis, N.C, van der Zee, A.G.J, van Doorn, H.C, van der Velden, J, Vergote, I, Zanagnolo, V, Baldwin, P.J, Gaarenstroom, K.N, van Dorst, E.B, Trum, J.W, Slangen, B.F.M, Runnebaum, I.B, Tamussino, K, Hermans, R.H, Provencher, D.M, de Bock, G.H, de Hullu, J.A, Oonk, M.H.M
Published in Gynecologic oncology (01.01.2016)
Published in Gynecologic oncology (01.01.2016)
Get full text
Journal Article
HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?
Fotopoulou, C., Sehouli, J., Mahner, S., Harter, P., Van Nieuwenhuysen, E., Gonzalez-Martin, A., Vergote, I., Chiva, L., Du Bois, A.
Published in Annals of oncology (01.08.2018)
Published in Annals of oncology (01.08.2018)
Get full text
Journal Article
Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D
Timmerman, S., Van Rompuy, A.S., Van Gorp, T., Vanden Bempt, I., Brems, H., Van Nieuwenhuysen, E., Han, S.N., Neven, P., Victoor, J., Laenen, A., Vergote, I.
Published in Gynecologic oncology (01.04.2020)
Published in Gynecologic oncology (01.04.2020)
Get full text
Journal Article
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
van Jaarsveld, M T M, Helleman, J, Boersma, A W M, van Kuijk, P F, van Ijcken, W F, Despierre, E, Vergote, I, Mathijssen, R H J, Berns, E M J J, Verweij, J, Pothof, J, Wiemer, E A C
Published in Oncogene (05.09.2013)
Published in Oncogene (05.09.2013)
Get full text
Journal Article
Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data
Raja, F.A., Counsell, N., Colombo, N., Pfisterer, J., du Bois, A., Parmar, M.K., Vergote, I.B., Gonzalez-Martin, A., Alberts, D.S., Plante, M., Torri, V., Ledermann, J.A.
Published in Annals of oncology (01.12.2013)
Published in Annals of oncology (01.12.2013)
Get full text
Journal Article